Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Neural Transm (Vienna) ; 121(6): 643-8, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24390153

RESUMEN

Oxidative stress is influenced by the thiol homeostasis, which regulates the redox milieu via glutathione. Components of glutathione metabolism are cysteine and cysteinyl-glycine. Both substrates decay following levodopa application or dopamine-related oxidative stress. Objective was to investigate the impact of an acute levodopa application with and without catechol-O-methyltransferase inhibitor on cysteine- and cysteinyl-glycine plasma levels. On two investigation days, 13 patients with Parkinson's disease took one retarded release 200-mg levodopa/50 mg carbidopa-containing tablet or one 150-mg levodopa/50-mg carbidopa/200-mg entacapone formulation under standardized conditions. Levodopa, 3-O-methyldopa, cysteine and cysteinyl-glycine were measured at baseline, 80 and 140 min following levodopa administration. Cysteine and cysteinyl-glycine similarly decreased, levodopa was nearly equal during both conditions. Entacapone lowered 3-O-methyldopa. Cysteine decay may be due to an elevated glutathione generation, which consumes cysteine. Cysteinyl-glycine decrease results from the alternative glutathione transformation to its oxidized form glutathione dissulfide after free radical scavenging.


Asunto(s)
Antiparkinsonianos/uso terapéutico , Catecol O-Metiltransferasa/metabolismo , Catecoles/uso terapéutico , Cisteína/sangre , Dipéptidos/sangre , Nitrilos/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Anciano , Análisis de Varianza , Antiparkinsonianos/sangre , Carbidopa/sangre , Carbidopa/uso terapéutico , Catecoles/sangre , Cromatografía de Fase Inversa , Sistemas de Liberación de Medicamentos , Femenino , Humanos , Levodopa/sangre , Levodopa/uso terapéutico , Masculino , Metildopa/sangre , Persona de Mediana Edad , Nitrilos/sangre , Enfermedad de Parkinson/sangre , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA